Graft Complexity–Related Outcomes of Fenestrated Endografting for Abdominal Aortic Aneurysms

Abstract

The use of FEVAR for juxta- and suprarenal aneurysms is associated with low 30-day mortality/morbidity and high midterm efficacy. So far, perioperative and midterm results are not affected by the use of more complex fenestrated designs.